{"status":"ok","message-type":"funder","message-version":"1.0.0","message":{"hierarchy-names":{"100030831":"Novartis Japan","100004336":"Novartis","100008792":"Novartis Pharma","100020193":"Novartis Australia","100014444":"Novartis Consumer Health","100011218":"Sandoz","100031645":"Novartis Italia","100012890":"Beijing Novartis Pharma","100007816":"Alcon","100015311":"Novartis Institutes for BioMedical Research","100009009":"Novartis Pharmaceuticals Canada","100009010":"Novartis Pharmaceuticals UK Limited","100032130":"Novartis Suomessa"},"replaced-by":[],"work-count":285,"name":"Sandoz","descendants":[],"descendant-work-count":285,"id":"100011218","tokens":["sandoz","sandoz","ag","sandoz","inc","sandoz","group","ag"],"replaces":[],"uri":"https:\/\/doi.org\/10.13039\/100011218","hierarchy":{"100004336":{"100030831":{},"100008792":{},"100020193":{},"100014444":{},"100011218":{},"100031645":{},"100012890":{},"100007816":{"more":true},"100015311":{},"100009009":{},"100009010":{},"100032130":{}}},"alt-names":["Sandoz AG","Sandoz Inc.","Sandoz Group AG"],"location":"United States"}}